Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
J Neurooncol ; 126(3): 415-24, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26518543

RESUMEN

A highly aggressive subgroup of the pediatric brain tumor medulloblastoma is characterized by overexpression of the proto-oncogene c-Myc, which encodes a transcription factor that normally maintains neural progenitor cells in an undifferentiated, proliferating state during embryonic development. Myc-driven medulloblastomas typically show a large-cell anaplastic (LCA) histological pattern, in which tumor cells display large, round nuclei with prominent nucleoli. This subgroup of medulloblastoma is therapeutically challenging because it is associated with a high rate of metastatic dissemination, which is a powerful predictor of short patient survival times. Genetically engineered mouse models have revealed important insights into the pathogenesis of medulloblastoma and served as preclinical testing platforms for new therapies. Here we report a new mouse model of Myc-driven medulloblastoma, in which tumors arise in situ after retroviral transfer and expression of Myc in Nestin-expressing neural progenitor cells in the cerebella of newborn mice. Tumor induction required concomitant loss of Tp53 or overexpression of the antiapoptotic protein Bcl-2. Like Myc-driven medulloblastomas in humans, the tumors induced in mice by Myc + Bcl-2 and Myc - Tp53 showed LCA cytoarchitecture and a high rate of metastatic dissemination to the spine. The fact that Myc - Tp53 tumors arose only in Tp53(-/-) mice, coupled with the inefficient germline transmission of the Tp53-null allele, made retroviral transfer of Myc + Bcl-2 a more practical method for generating LCA medulloblastomas. The high rate of spinal metastasis (87% of brain tumor-bearing mice) will be an asset for testing new therapies that target the most lethal aspect of medulloblastoma.


Asunto(s)
Carcinoma de Células Grandes/patología , Neoplasias Cerebelosas/patología , Modelos Animales de Enfermedad , Técnicas de Transferencia de Gen , Meduloblastoma/patología , Proteínas Proto-Oncogénicas c-bcl-2/genética , Proteínas Proto-Oncogénicas c-myc/genética , Animales , Carcinoma de Células Grandes/genética , Carcinoma de Células Grandes/metabolismo , Neoplasias Cerebelosas/genética , Neoplasias Cerebelosas/metabolismo , Femenino , Masculino , Meduloblastoma/genética , Meduloblastoma/metabolismo , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ratones Noqueados , Ratones Transgénicos , Proto-Oncogenes Mas , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Proteínas Proto-Oncogénicas c-myc/metabolismo , Transducción de Señal , Células Tumorales Cultivadas , Proteína p53 Supresora de Tumor/fisiología
2.
Small GTPases ; 10(1): 1-12, 2019 01.
Artículo en Inglés | MEDLINE | ID: mdl-28001501

RESUMEN

The activation of the small GTPase ARF6 has been implicated in promoting several pathological processes related to vascular instability and tumor formation, growth, and metastasis. ARF6 also plays a vital role during embryonic development. Recent studies have suggested that ARF6 carries out these disparate functions primarily by controlling protein trafficking within the cell. ARF6 helps direct proteins to intracellular or extracellular locations where they function in normal cellular responses during development and in pathological processes later in life. This transport of proteins is accomplished through a variety of mechanisms, including endocytosis and recycling, microvesicle release, and as yet uncharacterized processes. This Commentary will explore the functions of ARF6, while focusing on the role of this small GTPase in development and postnatal physiology, regulating barrier function and diseases associated with its loss, and tumor formation, growth, and metastasis.


Asunto(s)
Factores de Ribosilacion-ADP/fisiología , Factor 6 de Ribosilación del ADP , Animales , Desarrollo Embrionario , Endotelio Vascular/fisiología , Humanos , Neoplasias/enzimología , Neoplasias/patología , Transporte de Proteínas
3.
Clin Cancer Res ; 13(19): 5952-8, 2007 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-17908992

RESUMEN

PURPOSE: UV radiation is the major environmental risk factor for melanoma and a potent inducer of oxidative stress, which is implicated in the pathogenesis of several malignancies. We evaluated whether the thiol antioxidant N-acetylcysteine (NAC) could protect melanocytes from UV-induced oxidative stress/damage in vitro and from UV-induced melanoma in vivo. EXPERIMENTAL DESIGN: In vitro experiments used the mouse melanocyte line melan-a. For in vivo experiments, mice transgenic for hepatocyte growth factor and survivin, shown previously to develop melanoma following a single neonatal dose of UV irradiation, were given NAC (7 mg/mL; mother's drinking water) transplacentally and through nursing until 2 weeks after birth. RESULTS: NAC (1-10 mmol/L) protected melan-a cells from several UV-induced oxidative sequelae, including production of intracellular peroxide, formation of the signature oxidative DNA lesion 8-oxoguanine, and depletion of free reduced thiols (primarily glutathione). Delivery of NAC reduced thiol depletion and blocked formation of 8-oxoguanine in mouse skin following neonatal UV treatment. Mean onset of UV-induced melanocytic tumors was significantly delayed in NAC-treated compared with control mice (21 versus 14 weeks; P = 0.0003). CONCLUSIONS: Our data highlight the potential importance of oxidative stress in the pathogenesis of melanoma and suggest that NAC may be useful as a chemopreventive agent.


Asunto(s)
Acetilcisteína/farmacología , Melanocitos/metabolismo , Melanocitos/efectos de la radiación , Melanoma/tratamiento farmacológico , Melanoma/etiología , Neoplasias Inducidas por Radiación/tratamiento farmacológico , Estrés Oxidativo , Animales , Anticarcinógenos/farmacología , Humanos , Masculino , Ratones , Ratones Endogámicos C57BL , Dímeros de Pirimidina/química , Especies Reactivas de Oxígeno , Piel/efectos de los fármacos , Piel/metabolismo , Piel/efectos de la radiación , Rayos Ultravioleta
4.
Acta Neuropathol Commun ; 2: 85, 2014 Jul 25.
Artículo en Inglés | MEDLINE | ID: mdl-25059231

RESUMEN

Leptomeningeal dissemination (LMD), the metastatic spread of tumor cells via the cerebrospinal fluid to the brain and spinal cord, is an ominous prognostic sign for patients with the pediatric brain tumor medulloblastoma. The need to reduce the risk of LMD has driven the development of aggressive treatment regimens, which cause disabling neurotoxic side effects in long-term survivors. Transposon-mediated mutagenesis studies in mice have revealed numerous candidate metastasis genes. Understanding how these genes drive LMD will require functional assessment using in vivo and cell culture models of medulloblastoma. We analyzed two genes that were sites of frequent transposon insertion and highly expressed in human medulloblastomas: Arnt (aryl hydrocarbon receptor nuclear translocator) and Gdi2 (GDP dissociation inhibitor 2). Here we show that ectopic expression of Arnt and Gdi2 promoted LMD in mice bearing Sonic hedgehog (Shh)-induced medulloblastomas. We overexpressed Arnt and Gdi2 in a human medulloblastoma cell line (DAOY) and an immortalized, nontransformed cell line derived from mouse granule neuron precursors (SHH-NPD) and quantified migration, invasiveness, and anchorage-independent growth, cell traits that are associated with metastatic competence in carcinomas. In SHH-NPD cells. Arnt and Gdi2 stimulated all three traits. In DAOY cells, Arnt had the same effects, but Gdi2 stimulated invasiveness only. These results support a mechanism whereby Arnt and Gdi2 cause cells to detach from the primary tumor mass by increasing cell motility and invasiveness. By conferring to tumor cells the ability to proliferate without surface attachment, Arnt and Gdi2 favor the formation of stable colonies of cells capable of seeding the leptomeninges.


Asunto(s)
Neoplasias Cerebelosas/genética , Neoplasias Cerebelosas/patología , Proteínas Hedgehog/genética , Meduloblastoma , Neoplasias Meníngeas/secundario , Animales , Translocador Nuclear del Receptor de Aril Hidrocarburo/genética , Translocador Nuclear del Receptor de Aril Hidrocarburo/metabolismo , Línea Celular Tumoral , Movimiento Celular/genética , Técnicas de Transferencia de Gen , Inhibidores de Disociación de Guanina Nucleótido/genética , Inhibidores de Disociación de Guanina Nucleótido/metabolismo , Humanos , Meduloblastoma/genética , Meduloblastoma/patología , Meduloblastoma/secundario , Neoplasias Meníngeas/genética , Ratones , Ratones Transgénicos , Mutagénesis Insercional , Mutación/genética , Metástasis de la Neoplasia/genética , Transcriptoma , Ensayo de Tumor de Célula Madre
5.
Biomed Res Int ; 2013: 908797, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23555101

RESUMEN

We have recently reported a potential alternative tumor suppressor function for p16 relating to its capacity to regulate oxidative stress and observed that oxidative dysregulation in p16-depleted cells was most profound in melanocytes, compared to keratinocytes or fibroblasts. Moreover, in the absence of p16 depletion or exogenous oxidative insult, melanocytes exhibited significantly higher basal levels of reactive oxygen species (ROS) than these other epidermal cell types. Given the role of oxidative stress in melanoma development, we speculated that this increased susceptibility of melanocytes to oxidative stress (and greater reliance on p16 for suppression of ROS) may explain why genetic compromise of p16 is more commonly associated with predisposition to melanoma rather than other cancers. Here we show that the presence of melanin accounts for this differential oxidative stress in normal and p16-depleted melanocytes. Thus the presence of melanin in the skin appears to be a double-edged sword: it protects melanocytes as well as neighboring keratinocytes in the skin through its capacity to absorb UV radiation, but its synthesis in melanocytes results in higher levels of intracellular ROS that may increase melanoma susceptibility.


Asunto(s)
Melaninas/biosíntesis , Melanocitos/metabolismo , Melanoma/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Humanos , Queratinocitos/citología , Queratinocitos/metabolismo , Melaninas/metabolismo , Melanocitos/citología , Melanocitos/efectos de la radiación , Melanoma/patología , Oxidación-Reducción , Estrés Oxidativo/efectos de la radiación , Piel/metabolismo , Piel/patología , Piel/efectos de la radiación , Proteína p14ARF Supresora de Tumor , Rayos Ultravioleta
6.
J Invest Dermatol ; 133(4): 1043-51, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23190892

RESUMEN

Familial melanoma is associated with point mutations in the cyclin-dependent kinase (CDK) inhibitor p16(INK4A) (p16). We recently reported that p16 regulates intracellular oxidative stress in a cell cycle-independent manner. Here we constructed 12 different familial melanoma-associated point mutants spanning the p16 coding region and analyzed their capacity to regulate cell cycle phase and suppress reactive oxygen species (ROS). Compared with wild-type p16, which fully restored both functions in p16-deficient fibroblasts, various p16 mutants differed in their capacity to normalize ROS and cell cycle profiles. Although some mutations did not impair either function, others impaired both. Interestingly, several mutations impaired cell cycle (R24Q, R99P, and V126D) or oxidative functions (A36P, A57V, and P114S) selectively, indicating that these two functions of p16 can be uncoupled. Similar activities were confirmed with selected mutants in human melanoma cells. Many mutations impairing both cell cycle and oxidative functions, or only cell cycle function, localize to the third ankyrin repeat of the p16 molecule. Alternatively, most mutations impairing oxidative but not cell cycle function, or those not impairing either function, lie outside this region. These results demonstrate that particular familial melanoma-associated mutations in p16 can selectively compromise these two independent tumor-suppressor functions, which may be mediated by distinct regions of the protein.


Asunto(s)
Senescencia Celular/genética , Inhibidor p16 de la Quinasa Dependiente de Ciclina/genética , Genes Supresores de Tumor/fisiología , Melanoma/genética , Neoplasias Cutáneas/genética , Animales , Animales Recién Nacidos , Ciclo Celular/fisiología , Células Cultivadas , Inhibidor p16 de la Quinasa Dependiente de Ciclina/química , Inhibidor p16 de la Quinasa Dependiente de Ciclina/metabolismo , Fibroblastos/citología , Fibroblastos/fisiología , Melanoma/patología , Ratones , Estrés Oxidativo/genética , Mutación Puntual/genética , Estructura Terciaria de Proteína/genética , Especies Reactivas de Oxígeno/metabolismo , Neoplasias Cutáneas/patología , Relación Estructura-Actividad
7.
Science ; 313(5791): 1298-301, 2006 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-16873611

RESUMEN

The Caenorhabditis elegans anteroposterior axis is established in response to fertilization by sperm. Here we present evidence that RhoA, the guanine nucleotide-exchange factor ECT-2, and the Rho guanosine triphosphatase-activating protein CYK-4 modulate myosin light-chain activity to create a gradient of actomyosin, which establishes the anterior domain. CYK-4 is enriched within sperm, and paternally donated CYK-4 is required for polarity. These data suggest that CYK-4 provides a molecular link between fertilization and polarity establishment in the one-cell embryo. Orthologs of CYK-4 are expressed in sperm of other species, which suggests that this cue may be evolutionarily conserved.


Asunto(s)
Proteínas de Caenorhabditis elegans/fisiología , Caenorhabditis elegans/embriología , Polaridad Celular , Embrión no Mamífero/citología , Proteínas Activadoras de GTPasa/fisiología , Actomiosina/fisiología , Animales , Caenorhabditis elegans/fisiología , Proteínas de Caenorhabditis elegans/análisis , Proteínas de Caenorhabditis elegans/genética , Citocinesis , Citoesqueleto/fisiología , Embrión no Mamífero/química , Embrión no Mamífero/fisiología , Femenino , Fertilización , Proteínas Activadoras de GTPasa/análisis , Proteínas Activadoras de GTPasa/genética , Factores de Intercambio de Guanina Nucleótido/análisis , Factores de Intercambio de Guanina Nucleótido/genética , Factores de Intercambio de Guanina Nucleótido/fisiología , Masculino , Cadenas Ligeras de Miosina/metabolismo , Miosina Tipo II/análisis , Orgánulos/química , Proteínas/análisis , Interferencia de ARN , Espermatozoides/química , Espermatozoides/ultraestructura , Proteína de Unión al GTP rhoA/genética , Proteína de Unión al GTP rhoA/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA